Abstract:Objective To evaluate the efficacy of patients with stage T2 bladder cancer who underwent combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy.Methods The survival data of bladder cancer paients from January 2000 to December 2014 with stage T2N0M0 were retrospectively analyzed.Thirty-five patients of cT2N0M0 receive combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy(group A),and 80 patients of pT2N0M0 underwent radical cystectomy (RC) (group B).The pathological diagnosis of all patients was urothelial carcinoma.In group A,there were 33(94.2％) males and 2 (5.8％) females;20 (57.1％) tumor size less than 3 cm and 15 (42.9％) larger than 3 cm;24 (68.6％) with single tumor and 11 (31.4％) with multiple tumors;11 (31.4％) patients with primary tumors and 24 (68.6％) recurrent tumors.In group B,there were 71 (88.7％) males and 9 (11.3％) females;35 (43.8％) tumor size less than 3 cm and 45(56.2％) larger than 3 cm;44 (55.0％) with single tumors and 36 (45.0％) with multiple tumors;22(27.5％) patients with primary tumors and 58 (72.5％) recurrent tumors.Results Groups A and B consisted of 35 and 80 patients and median follow-up time was 68 (13-157)and 67 (4-198)months,respectively.There was no significantly statistical difference in disease-specific survival (DSS) between the two groups(P =0.888),76.5％ for group A and 60.6％ for group B respectively.In group A,26 (74.3％) patients achieved complete response (CR) to intra-arterial chemotherapy.Additionally,amounts of 21 (60.0％) patients preserve their functional bladder successfully and their median follow-up time was 69 (13-134)months.8 patients receive delayed radical cystectomy when suffered tumor recurrence and none of them had lymph node metastases.Of those pathological stage was presented as stage T2 5 cases,T3 2 cases and T4 1 case.Importantly,the 8 patients who receive delayed RC did not confer worse DSS when compared with those underwent immediate RC in group B (P =0.809).Cox proportional hazards model showed that tumor number and CR to intra-arterial chemotherapy was independent prognostic factor for disease-free survival (HR =0.238,P =0.007) and DSS(HR =0.085,P =0.004) respectively.During the period of intra-arterial chemotherapy,we did not observe hematological toxicity of grade Ⅳ and the hematological toxicity of grade Ⅰ-Ⅲ was 9 (25.7％),6 (17.1％) and 4 (11.4％).Conclusions For patients with T2N0M0,combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy could be a therapy with long-term survival outcome and safety.The therapy could be offered as alternative treatment option for patients who were unsuitable for receiving RC.

Combinations of Intra-Artery Chemotherapy and Bladder-Preserving Resection for Primary T1G3 Bladder Cancer

Combined Modality Therapy Following Bladder Conservation Surgery for Bladder Cancers

Effect of Post Bladder Sparing Operation Intra-Arterial Chemotherapy Combined with Intravesical Chemotheraoy for the Treatment of T1G3 Bladder Urothelial Carcinoma

Preliminary results of intra-artery chemotherapy for T1G3 bladder cancer

Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer

Long-term Outcomes of Combined Treatment of Bladder-Preserving Surgery and Adjuvant Intraarterial Chemotherapy for Patients with Stage T2 Bladder Cancer

Combinations of Internal lliac Arterial Chemotherapy and Bladderpreserving Resection for Local Invasive Bladder Cancer

The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer

Combinations of neoadjuvant chemotherapy and transurethral resection for invasive bladder cancer

Efficacy of Intra-Arterial Chemotherapy Combined with Intravesical Chemotherapy in T1G3 Bladder Cancer when Compared with Intravesical Chemotherapy Alone after Bladder-Sparing Surgery: a Retrospective Study

Management of Primary T1G3 Bladder Cancer: Immediate Cystectomy or Bladder Preserving Approach?

Transurethral Electric Resection Plus Arterial Catheterization Chemotherapy for T2a Bladder Carcinoma

The effects of intra-arterial chemotherapy on bladder preservation in patients with T1 stage bladder cancer

Combined-Modality Treatment for High Risk TCC of the Bladder

The clinical study of intra-arterial chemotherapy followed by bladder-preserving surgery for high-risk non muscle-invasive bladder cancer

Intra-Arterial Chemotherapy for Muscle-Invasive Bladder Cancer Following Transurethral Resection

A Novel Treatment Strategy for Newly Diagnosed High-Grade T1 Bladder Cancer: Gemcitabine and Cisplatin Adjuvant Chemotherapy-a Single-Institution Experience

Comparing Intra-Arterial Chemotherapy Combined with Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone: A Randomised Prospective Pilot Study for T1G3 Bladder Transitional Cell Carcinoma after Bladder-Preserving Surgery

Combination of Hyperthermia and Intravesical Chemotherapy for the Treatment of Pt1 Stage Bladder Cancer: A Retrospectively Clinical Study.

Initial Results of Intra-arterial Chemotherapy for Poorly Differentiated Bladder Transitional Cell Carcinoma

Efficacy of salvage intra-arterial chemotherapy after transurethral resection of bladder tumor for muscle invasive bladder cancer